Pharma Tech

Market Access Trends in the US, Europe, and Emerging Markets

November 14, 2022

Market Access
Rising drug spending and increased desire for expenditure controls are consistent themes across the US, Europe, and emerging markets.

Spotlight

Novel Laboratories, Inc

Founded in December of 2006 by industry veteran, Dr. Veerappan Subramanian, Novel Laboratories, Inc. is a full-service pharmaceutical company that develops, manufactures, markets and distributes niche and difficult to develop new and generic technology-based drug products to the US and European markets.

OTHER WHITEPAPERS
news image

Characterization of Protein Aggregates and Other Particles in Biopharmaceuticals

whitePaper | July 8, 2022

Particulates are ubiquitous in parenteral drug products and remain a concern throughout their development and production1–3. These particles must be monitored to satisfy.

Read More
news image

Considerations for migrating a drug product presentation from vial to pre-filled syringe

whitePaper | December 9, 2022

There is an upward trend for pharmaceutical companies to ask their contract development and manufacturing organisations (CDMO) to support the conversion.

Read More
news image

Non-Clinical Testing Considerations: Drugs vs Devices

whitePaper | November 8, 2022

While drugs and devices differ in their development, clinical trial phases and regulatory guidelines, the most important difference is that medical devices do not achieve their principal action by pharmacological means.

Read More
news image

Demystifying content marketing for the pharma industry

whitePaper | November 10, 2022

We know people don’t like to be sold to. And in the so-called ‘attention economy’, it is more important than ever that your business can utilise meaningful marketing and advertising practices to engage with your customers and secure their attention.

Read More
news image

Advancing drug development using in silico modeling

whitePaper | June 22, 2022

The technologic and pharmacologic advances that have enabled researchers to take aim at previously untreatable diseases have contributed to an increase in the number of molecules in the development pipeline that are challenging and difficult to manufacture.

Read More
news image

Achieving diversity, equity and inclusion in clinical trials

whitePaper | April 26, 2022

The prevalence of communicable and non-communicable diseases are increasing worldwide, placing considerable demand on public health systems and driving a necessity to develop more effective targeted therapies.

Read More

Spotlight

Novel Laboratories, Inc

Founded in December of 2006 by industry veteran, Dr. Veerappan Subramanian, Novel Laboratories, Inc. is a full-service pharmaceutical company that develops, manufactures, markets and distributes niche and difficult to develop new and generic technology-based drug products to the US and European markets.

Events